Engelsk titel: Recombinant human DNase in conditions other than cystic fibrosis
Läs online
Författare:
Kristensen, Kim
Email: kimk@dadlnet.dk
Språk: Dan
Antal referenser: 25
Dokumenttyp:
Översikt
UI-nummer: 10021495
Sammanfattning
Recombinant human DNase (rhDNase) reduces viscosity of sputum. Effect has been documented in cystic fibrosis and postoperatively in paediatric heart disease. Single dose treatment with rhDNase in paediatric asthma has no effect. In respiratory syncytial virus infection, treatment with rhDNase may be associated with increased need for supplemental oxygen. In adults with idiopathic bronchiectasis, treatment with rhDNase leads to more pulmonary exacerbations and a greater decline in pulmonary function tests. There are no controlled studies on rhDNase in primary ciliary dyskinesia or atelectasis.